This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Avive® Is A Software-based Pharmacy System With Proven Benefits Across Patient, Payer And Provider Needs That Increases Medication Adherence, Pharmacy Efficiency And CMS Star Ratings (Photo: Business Wire)

Stocks in this article: MWV

MeadWestvaco Corp. (NYSE: MWV), a global leader in packaging and packaging solutions, today announced the commercial availability of the Avive® Multimed system, a software-based solution that establishes a pharmacy home, synchronizes medication regimens, improves adherence, supports reimbursement for services including medication therapy management and helps dramatically improve CMS Star Ratings performance. Avive is unique among pharmacy solutions because it offers multiple benefits in one seamless, proprietary software system.

Avive® is a software-based pharmacy system with proven benefits across patient, payer and provider n ...

Avive® is a software-based pharmacy system with proven benefits across patient, payer and provider needs that increases medication adherence, pharmacy efficiency and CMS Star Ratings (Photo: Business Wire)

MWV Healthcare and its partner, LTCPCMS, Inc., developed the Avive system to decrease the complexities of poly-pharmacy. Avive is designed to provide pharmacists and health care management personnel with software tools and workflow to create synchronized, personalized medication regimens. These regimens drive patient adherence by accommodating their input and activities of daily living. The Avive solution is supported by pending patents.

“We have successfully used the Avive solution in a test environment for nearly two years on a very adherence-challenged patient population with multiple chronic diseases,” said Tom Grinnan, senior director, Healthcare Innovation & EU Adherence, MWV. “The data has shown that Avive is distinctly successful in achieving a full pharmacy home and improving refill rates. We are now ready to license this unique program to pharmacy partners, developers and PBMs.”

Avive addresses the growing number of people in the United States suffering from co-morbidities who are taking an increasing number of medications, prescribed by a number of physicians and purchased from a myriad of pharmacies. Research shows that by synchronizing these medications with one pharmacy home, patients can experience better health outcomes, health-related expenses are lowered and refill rates rise dramatically.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs